Paxil Birth Defect Suit Filed By Affiliate On Behalf of Child Born With Aortic Stenosis

Top Quote reports that one of its member firms has filed a case in the Court of Common Pleas in Philadelphia on behalf of an infant who was born with significant heart defects after his mother used Paxil while pregnant End Quote
  • New York, NY (1888PressRelease) September 19, 2008 - A attorney has filed an action on behalf of infant, "JB" against Glaxo SmithKline in the Court of Common Pleas in Philadelphia.

    JB's mother was prescribed the antidepressant Paxil during her first trimester, by her physician who was unaware of any contraindication related to pregnancy. The pregnancy proceeded without incident and JB was delivered at full term.

    After leaving the hospital the child began to experience problems and was eventually referred toa pediatric cardiologist. An echocardiogram was performed and the parrents were informed that baby JB had a number of cardiac deformities including severe aoritic stenosis, coarctation of the aortic valve and mitral stenosis.

    At only 5 months of age baby JB underwent a balloon valvuloplasty to improve blood flow through the aorta.

    Now five years old baby JB has been scheduled for a another heart operation and is likely to have many more before he graduates elementary school.

    Over the years, the safety of Paxil has been questioned. On December 13, 2005, Glaxo SmithKline released a follow up to a prior study comparing the effects of bupropion to other antidepressants. The preliminary study and it follow up are available on the GSK website. GSK concluded that the use of paroxetine in the first trimester of pregnancy was associated with an increased risk of congenital malformations, and a trend towards an increased risk of cardiovascular malformations, compared with the use of other antidepressants.

    Hundreds of cases have been filed against Glaxo SmithKline claiming that children were born with significant congenital cardiac abnormalities after there mothers used Paxil during pregnancy. The first trial is expected to take place this winter.

    Noble McIntyre of Nix & McIntyre, LLP, attorneys for the infant is currently representing about a dozen other children who have suffered similar injuries as result of exposure to Paxil., reports that Glaxo continues to market their product and advise against discontinuing use of Paxil during pregnancy despite the increased risk for birth defects.

    If you or someone you know suffers from an injury, birth defects, or other side effects, or if you have lost a loved one due to these dangers, you are not alone and you deserve answers. Make sure to contact the experienced, and knowledgeable birth defect lawyers at

  • FB Icon Twitter Icon In-Icon
Contact Information